# EDGAR Filing Document

**Accession Number:** 0001934850
**File Stem:** 0000000000-25-006461
**Filing Date:** 2025-6
**Character Count:** 4308
**Document Hash:** cc62ff941356c141bb2bab00a0729994
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006461.hdr.sgml**: 20260630

**ACCESSION NUMBER**: 0000000000-25-006461

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250620

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** F&G Annuities & Life, Inc.
- **CENTRAL INDEX KEY:** 0001934850
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 852487422
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 001-41490

**BUSINESS ADDRESS:**
- **STREET 1:** 801 GRAND AVE, SUITE 2600
- **CITY:** DES MOINES
- **STATE:** IA
- **ZIP:** 50309
- **BUSINESS PHONE:** 866-846-4660

**MAIL ADDRESS:**
- **STREET 1:** 801 GRAND AVE, SUITE 2600
- **CITY:** DES MOINES
- **STATE:** IA
- **ZIP:** 50309
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001934850-25-000015

## Text-Extract

```

                                                           June 20, 2025

Conor Murphy
Chief Financial Officer
F&G Annuities & Life, Inc.
801 Grand Avenue
Des Moines, Iowa 50309

       Re: F&G Annuities & Life, Inc.
           Form 10-K for Fiscal Year Ended December 31, 2024
           Form 8-K Filed February 20, 2025
           File No. 001-41490
Dear Conor Murphy :

       We have reviewed your May 23, 2025 response to our comment letter and
have the
following comments.

       Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

       After reviewing your response to this letter, we may have additional
comments.

Form 10-K for Fiscal Year Ended December 31, 2024
Non-GAAP Financial Measures, page 87

1.     We note you disclose that you eliminate the changes in the fair value of
market risk
       benefits by deferring current period changes and amortizing that amount
over the life
       of the market risk benefit. Please address the following:
           Please quantify each component of this adjustment for 2024, 2023 and
the quarter
           ended March 31, 2025.
           Please explain to us why you believe this adjustment is needed to
provide a useful
           profitability measure for investors. Please discuss any asymmetrical
or
           noneconomic accounting that is being addressed by this adjustment
and
           specifically tell us how the assets that hedge this liability are
accounted for.
           Specifically address how amortizing the amounts over the life of the
market risk
           benefit results in a useful measure.
           Please tell us how you considered whether the adjustment results in
a misleading
           non-GAAP measure that violates Rule 100(b) of Regulation G.
 June 20, 2025
Page 2

       Refer to Question 100.04 of the Compliance and Disclosure
Interpretations on Non-
       GAAP Financial Measures for guidance.
Form 8-K Filed May 7, 2025
General

2.     Your presentation of Adjusted Net Earnings     Management View on slide
5 appears
       to be a non-GAAP income statement. Please note that the presentation of
a non-
       GAAP income statement may place undue prominence on the non-GAAP
       information. Under Question 102.10(c) of the C&DI's on Non-GAAP
Financial
       Measures, a non-GAAP income statement is considered to be one that is
comprised of
       non-GAAP measures and includes all or most of the line items and
subtotals found in
       a GAAP income statement. Please confirm to us that you will not present
a non-
       GAAP income statement in future filings subject to Item 10(e)(1)(i) of
Regulation S-
       K.
       Please contact Michael Volley at 202-551-3437 or Amit Pande at
202-551-3423 if
you have questions regarding comments on the financial statements and related
matters.

                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of Finance

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._